Many providers appear unaware that insulin syringes are covered under the new Medicare prescription drug program, according to Can-Am Care LLC, Alpharetta, Ga., one of the largest suppliers of branded and private-label syringes. Can-Am conducted a survey of more than 100 help desk operators at Part D providers and found that many offered confusing information and were unaware that the new benefit covers syringes. In addition, the company pointed out that the Web site at www.medicare.gov http://www.medicare.govdoes not provide information about newly covered supplies such as insulin syringes and pen needles.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.